Literature DB >> 21622531

Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo.

Liming Wang1, Jae-Hyung Chang, Seung-Yeol Paik, Yuping Tang, William Eisner, Robert F Spurney.   

Abstract

To determine the role of Gq signaling and calcineurin (CN) activation in promoting apoptosis of glomerular podocytes, constitutively active Gq [Gq(+)] or CN [CN(+)] proteins were introduced into cultured podocytes using protein transduction by tagging the proteins with the transactivator of transcription peptide. To investigate the role of CN in promoting podocyte apoptosis in vivo, a genetic model of type 1 diabetes mellitus (Akita mice) was treated with the CN inhibitor FK506. In cultured podocytes, Gq(+) stimulated nuclear translocation of nuclear factor of activated T cells (NFAT) family members, activated an NFAT reporter construct, and enhanced podocyte apoptosis in a CN-dependent fashion. CN(+) similarly promoted podocyte apoptosis, and apoptosis induced by either angiotensin II or endothelin-1 was blocked by FK506. Induction of apoptosis required NFAT-induced gene transcription because apoptosis induced by either Gq(+) or CN(+) was blocked by an inhibitor that prevented CN-dependent NFAT activation without affecting CN phosphatase activity. Podocyte apoptosis was mediated, in part, by the NFAT-responsive gene cyclooxygenase 2 (COX2) and prostaglandin E(2) generation because apoptosis induced by Gq(+) was attenuated by either COX2 inhibition or blockade of the Gq-coupled E-series prostaglandins receptor. The findings appeared relevant to podocyte apoptosis in diabetic nephropathy because apoptosis was significantly reduced in Akita mice by treatment with FK506. These data suggest that Gq stimulates CN and promotes podocyte apoptosis both in vitro and in vivo. Apoptosis requires NFAT-dependent gene transcription and is mediated, in part, by CN-dependent COX2 induction, prostaglandin E(2) generation, and autocrine activation of the Gq-coupled E-series prostaglandins receptor.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622531      PMCID: PMC3146249          DOI: 10.1210/me.2011-0029

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  51 in total

1.  Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells.

Authors:  G Kalinec; A J Nazarali; S Hermouet; N Xu; J S Gutkind
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

2.  A new cell-permeable peptide allows successful allogeneic islet transplantation in mice.

Authors:  Hirofumi Noguchi; Masayuki Matsushita; Teru Okitsu; Akiyoshi Moriwaki; Kazuhito Tomizawa; Sunghyun Kang; Sheng-Tian Li; Naoya Kobayashi; Shinichi Matsumoto; Koich Tanaka; Noriaki Tanaka; Hideki Matsui
Journal:  Nat Med       Date:  2004-02-08       Impact factor: 53.440

3.  Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy.

Authors:  S A Akhter; L M Luttrell; H A Rockman; G Iaccarino; R J Lefkowitz; W J Koch
Journal:  Science       Date:  1998-04-24       Impact factor: 47.728

Review 4.  Transcription factors of the NFAT family: regulation and function.

Authors:  A Rao; C Luo; P G Hogan
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 5.  Fructosamine: structure, analysis, and clinical usefulness.

Authors:  D A Armbruster
Journal:  Clin Chem       Date:  1987-12       Impact factor: 8.327

6.  Direct demonstration of NFATp dephosphorylation and nuclear localization in activated HT-2 cells using a specific NFATp polyclonal antibody.

Authors:  V A Ruff; K L Leach
Journal:  J Biol Chem       Date:  1995-09-22       Impact factor: 5.157

7.  FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin.

Authors:  S J O'Keefe; J Tamura; R L Kincaid; M J Tocci; E A O'Neill
Journal:  Nature       Date:  1992-06-25       Impact factor: 49.962

8.  Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.

Authors:  P S Kontessis; S L Jones; S E Barrow; P D Stratton; P Alessandrini; S De Cosmo; J M Ritter; G C Viberti
Journal:  J Lab Clin Med       Date:  1993-03

9.  Inhibition of human glioma cell growth by a PHS-2 inhibitor, NS398, and a prostaglandin E receptor subtype EP1-selective antagonist, SC51089.

Authors:  Muneaki Matsuo; Nobuyuki Yoshida; Masahumi Zaitsu; Kiyohisa Ishii; Yuhei Hamasaki
Journal:  J Neurooncol       Date:  2004-02       Impact factor: 4.130

10.  Involvement of calcineurin in transforming growth factor-beta-mediated regulation of extracellular matrix accumulation.

Authors:  Jennifer L Gooch; Yves Gorin; Bin-Xian Zhang; Hanna E Abboud
Journal:  J Biol Chem       Date:  2004-01-23       Impact factor: 5.157

View more
  35 in total

1.  A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension.

Authors:  Jian-dong Zhang; Mehul B Patel; Young-Soo Song; Robert Griffiths; James Burchette; Phillip Ruiz; Matthew A Sparks; Ming Yan; David N Howell; Jose A Gomez; Robert F Spurney; Thomas M Coffman; Steven D Crowley
Journal:  Circ Res       Date:  2012-04-24       Impact factor: 17.367

2.  Transforming growth factor-β1 and phosphatases modulate COX-2 protein expression and TAU phosphorylation in cultured immortalized podocytes.

Authors:  Maya S Abdallah; Christopher R J Kennedy; Joseph S Stephan; Pamela Abou Khalil; Mohammad Mroueh; Assaad A Eid; Wissam H Faour
Journal:  Inflamm Res       Date:  2017-10-30       Impact factor: 4.575

3.  Gq signaling causes glomerular injury by activating TRPC6.

Authors:  Liming Wang; Grant Jirka; Paul B Rosenberg; Anne F Buckley; Jose A Gomez; Timothy A Fields; Michelle P Winn; Robert F Spurney
Journal:  J Clin Invest       Date:  2015-04-06       Impact factor: 14.808

4.  MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes.

Authors:  Junnan Wu; Chunxia Zheng; Xiao Wang; Shifeng Yun; Yue Zhao; Lin Liu; Yuqiu Lu; Yuting Ye; Xiaodong Zhu; Changming Zhang; Shaolin Shi; Zhihong Liu
Journal:  J Clin Invest       Date:  2015-10-05       Impact factor: 14.808

5.  Sustained activation of N-methyl-D-aspartate receptors in podoctyes leads to oxidative stress, mobilization of transient receptor potential canonical 6 channels, nuclear factor of activated T cells activation, and apoptotic cell death.

Authors:  Eun Young Kim; Marc Anderson; Stuart E Dryer
Journal:  Mol Pharmacol       Date:  2012-07-24       Impact factor: 4.436

6.  Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.

Authors:  Liming Wang; Yonggang Sha; Jingyi Bai; William Eisner; Matthew A Sparks; Anne F Buckley; Robert F Spurney
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-10

7.  Tacrolimus is an alternative therapy option for the treatment of adult steroid-resistant nephrotic syndrome: a prospective, multicenter clinical trial.

Authors:  Li Fan; Qinghua Liu; Yunhua Liao; Zhibin Li; Yulian Ji; Zhenhua Yang; Jian Chen; Junzhou Fu; Jinli Zhang; Yaozhong Kong; Ping Fu; Tanqi Lou; Zhengrong Liu; Xueqing Yu; Wei Chen
Journal:  Int Urol Nephrol       Date:  2012-06-09       Impact factor: 2.370

8.  NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.

Authors:  Li Zhang; Ruizhao Li; Wei Shi; Xinling Liang; Shuangxin Liu; Zhiming Ye; Chunping Yu; Yuanhan Chen; Bin Zhang; Wenjian Wang; Yuxiong Lai; Jianchao Ma; Zhuo Li; Xiaofan Tan
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

9.  Triptolide protects podocytes from TGF-β-induced injury by preventing miR-30 downregulation.

Authors:  Qianqian Yang; Mengjie Sun; Ying Chen; Yuqiu Lu; Yuting Ye; Hui Song; Xiaodong Xu; Shaolin Shi; Jinquan Wang
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 10.  Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.

Authors:  Stacy A Johnson; Robert F Spurney
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.